drugset / Trial / NCT06877611
A Phase 1 Study of S-4321
RandomizedParallel-groupDouble-blindTreatment
Summary
This is the first-in-human study of S-4321 designed to provide safety, tolerability, pharmacokinetic, and pharmacodynamic data in healthy volunteers.
Timeline
- Start
- 2025-04-03
- Primary completion
- 2026-04
- Completion
- 2026-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | S-4321 | Unknown | — | Subcutaneous |
Indications
No indication recorded.